Forte Biosciences Stock Alpha and Beta Analysis

FBRX Stock  USD 15.52  0.12  0.77%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Forte Biosciences. It also helps investors analyze the systematic and unsystematic risks associated with investing in Forte Biosciences over a specified time horizon. Remember, high Forte Biosciences' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Forte Biosciences' market risk premium analysis include:
Beta
1.74
Alpha
1.57
Risk
16.68
Sharpe Ratio
0.11
Expected Return
1.78
Please note that although Forte Biosciences alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Forte Biosciences did 1.57  better than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Forte Biosciences stock's relative risk over its benchmark. Forte Biosciences has a beta of 1.74  . As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Forte Biosciences will likely underperform. Book Value Per Share is likely to drop to 26.57 in 2024. Tangible Book Value Per Share is likely to drop to 26.57 in 2024.

Enterprise Value

15.27 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Forte Biosciences Backtesting, Forte Biosciences Valuation, Forte Biosciences Correlation, Forte Biosciences Hype Analysis, Forte Biosciences Volatility, Forte Biosciences History and analyze Forte Biosciences Performance.
For more information on how to buy Forte Stock please use our How to Invest in Forte Biosciences guide.

Forte Biosciences Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Forte Biosciences market risk premium is the additional return an investor will receive from holding Forte Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Forte Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Forte Biosciences' performance over market.
α1.57   β1.74

Forte Biosciences expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Forte Biosciences' Buy-and-hold return. Our buy-and-hold chart shows how Forte Biosciences performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Forte Biosciences Market Price Analysis

Market price analysis indicators help investors to evaluate how Forte Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Forte Biosciences shares will generate the highest return on investment. By understating and applying Forte Biosciences stock market price indicators, traders can identify Forte Biosciences position entry and exit signals to maximize returns.

Forte Biosciences Return and Market Media

The median price of Forte Biosciences for the period between Sat, Aug 24, 2024 and Fri, Nov 22, 2024 is 5.68 with a coefficient of variation of 31.82. The daily time series for the period is distributed with a sample standard deviation of 1.98, arithmetic mean of 6.23, and mean deviation of 1.45. The Stock received some media coverage during the period.
 Price Growth (%)  
       Timeline  
1
Disposition of 9375 shares by Riley Antony A of Forte Biosciences subject to Rule 16b-3
09/06/2024
2
Insider Trading
09/17/2024
3
Disposition of 1250 shares by Paul Wagner of Forte Biosciences subject to Rule 16b-3
10/01/2024
4
Perceptive Advisors LLC Acquires Shares in Forte Biosciences Inc
11/15/2024
5
Forte Biosciences Shares Are Soaring Today Whats Going On
11/20/2024

About Forte Biosciences Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Forte or other stocks. Alpha measures the amount that position in Forte Biosciences has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2018 2023 2024 (projected)
Interest Debt Per Share493.0554.9252.17
Revenue Per Share337.17303.45318.63

Forte Biosciences Upcoming Company Events

As portrayed in its financial statements, the presentation of Forte Biosciences' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Forte Biosciences' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Forte Biosciences' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Forte Biosciences. Please utilize our Beneish M Score to check the likelihood of Forte Biosciences' management manipulating its earnings.
29th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
29th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Forte Biosciences

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Forte Stock Analysis

When running Forte Biosciences' price analysis, check to measure Forte Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Forte Biosciences is operating at the current time. Most of Forte Biosciences' value examination focuses on studying past and present price action to predict the probability of Forte Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Forte Biosciences' price. Additionally, you may evaluate how the addition of Forte Biosciences to your portfolios can decrease your overall portfolio volatility.